Clinical Trial Update: Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating concurrent chemoradiotherapy with paclitaxel plus cisplatin in locally advanced non-small-cell lung cancer, with the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Non-small-cell Lung Cancer | Phase 4 | Status: COMPLETED